Etges, T., Karolia, K., Grint, T., Taylor, A., Lauder, H., Daka, B., & Wright, S. (2016). An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC: CBD, nabiximols) oromucosal spray. Ther Clin Risk Manag.
Citação norma ChicagoEtges, Tilden, Kari Karolia, Thomas Grint, Adam Taylor, Heather Lauder, Brian Daka, and Stephen Wright. "An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland Who Have Been Prescribed Sativex(®) (THC: CBD, Nabiximols) Oromucosal Spray." Ther Clin Risk Manag 2016.
Citação norma MLAEtges, Tilden, et al. "An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland Who Have Been Prescribed Sativex(®) (THC: CBD, Nabiximols) Oromucosal Spray." Ther Clin Risk Manag 2016.